Please wait while the formulary information is being retrieved.
DIBENZYLINE (PHENOXYBENZAMINE HCL)
- Pheochromocytoma adjunct therapy
phenoxybenzamine 10 mg capsule
- 1 capsule (10 mg) by oral route 2 times per day
10 mg capsule
- 1 capsule (10 mg) by oral route 2 times per day
Pheochromocytoma adjunct therapy
- 1 capsule (10 mg) by oral route 3 times per day
- 1 capsule (10 mg) by oral route 2 times per day
- 2 capsules (20 mg) by oral route 2 times per day
- 2 capsules (20 mg) by oral route 3 times per day
- 3 capsules (30 mg) by oral route 2 times per day
- 3 capsules (30 mg) by oral route 3 times per day
- 4 capsules (40 mg) by oral route 2 times per day
- 4 capsules (40 mg) by oral route 3 times per day
- None
Contraindicated
- None
Severe
Moderate
- Adcirca
- avanafil
- Cialis
- Levitra
- Revatio
- sildenafil
- Stendra
- tadalafil
- vardenafil
- Viagra
- Severe hypotension
Contraindicated
- None
Severe
Moderate
- Cerebrovascular insufficiency
- Coronary artery disease
- Kidney disease with reduction in GFR
- Lower respiratory infection
DIBENZYLINE (PHENOXYBENZAMINE HCL)
- Pheochromocytoma adjunct therapy
- None
- Miosis
- Nasal congestion
- Orthostatic hypotension
- Tachycardia
More Frequent
Severe
Less Severe
- None
- Acute confusion
- Disorder of ejaculation
- Drowsy
- Fatigue
- Headache disorder
- Xerostomia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- None
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Phenoxybenzamine
Safety and efficacy not established.
- 1 Day – 18 Years
- Safety and efficacy not established.
Phenoxybenzamine Hydrochloride
- Severity Level:
C
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Phenoxybenzamine Hydrochloride
Insuff. data avail. molecular wt low enough for possible breastmilk excretion
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insuff. data avail. molecular wt low enough for possible breastmilk excretion |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Phenoxybenzamine
Increased risk of hypotension and tachycardia. Caution in cardiovascular or renal disease.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | N | Y | N | N | N |
BEERS: N HEDIS: N STOPP: Y
No Known Risk
None
- None
| Pheochromocytoma adjunct therapy | |
| C74.1 | Malignant neoplasm of medulla of adrenal gland |
| C74.10 | Malignant neoplasm of medulla of unspecified adrenal gland |
| C74.11 | Malignant neoplasm of medulla of right adrenal gland |
| C74.12 | Malignant neoplasm of medulla of left adrenal gland |
| D35.0 | Benign neoplasm of adrenal gland |
| D35.00 | Benign neoplasm of unspecified adrenal gland |
| D35.01 | Benign neoplasm of right adrenal gland |
| D35.02 | Benign neoplasm of left adrenal gland |
| E31.22 | Multiple endocrine neoplasia [MEn] type IIA |
| E31.23 | Multiple endocrine neoplasia [MEn] type IIB |
| 0-9 | A-Z |
|---|---|
| C74.1 | Malignant neoplasm of medulla of adrenal gland |
| C74.10 | Malignant neoplasm of medulla of unspecified adrenal gland |
| C74.11 | Malignant neoplasm of medulla of right adrenal gland |
| C74.12 | Malignant neoplasm of medulla of left adrenal gland |
| D35.0 | Benign neoplasm of adrenal gland |
| D35.00 | Benign neoplasm of unspecified adrenal gland |
| D35.01 | Benign neoplasm of right adrenal gland |
| D35.02 | Benign neoplasm of left adrenal gland |
| E31.22 | Multiple endocrine neoplasia [MEn] type IIA |
| E31.23 | Multiple endocrine neoplasia [MEn] type IIB |
Formulary Reference Tool